Rifametane

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameRifametane
Drug Alias Name利福美坦rifametanorifametanumSPA-S-565CGP-40469A
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionProtein biosynthesis inhibitors
TargetsNot applicable
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSocieta Prodotti AntibioticiNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSocieta Prodotti AntibioticiNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksKEGG